Home | Welcome to Contract Pharma   
Last Updated Monday, April 21 2014
Print

Harlan Labs Appoints BD Director



By Kristin Brooks



Published February 4, 2014
Related Searches: CRO contractpharma.com Development Preclinical
Urvashi Gupta has been appointed director of business development for Harlan Laboratories Research Models and Services (RMS) business unit in Asia. Ms. Gupta will focus on expanding Harlan's market position and new business initiatives, including key strategic partnerships and leading corporate development efforts. She will also oversee a team of business development managers in Japan and Korea, and will have responsibility for agents in China, Singapore, Hong Kong, Malaysia and Australia.
 
Ms. Gupta has 13 years of experience in research, operations, client relations and sales throughout Asia, Europe and the U.S. Most recently, she served as business development manager for Covance, where she was responsible for all sales initiatives in India with a focus on expanding the company's presence throughout the region. She also worked as an operations manager and research scientist with Covance.

"As the preclinical research market continues to establish roots and grow outside of North America and Europe, now is the perfect time to expand our already talented business development group," said Stuart Frith, global vice president of business development at Harlan Laboratories. "We're excited to add Urvashi to our team, and her wealth of international experience in the CRO and pharmaceutical industries will be an asset to Harlan as we continue to expand in Asia."  


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On